CARNITINE DEFICIENCY INDUCED BY PIVAMPICILLIN AND PIVMECILLINAM THERAPY
- 1 August 1989
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 334 (8661), 469-473
- https://doi.org/10.1016/s0140-6736(89)92086-2
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Transport of carnitine into cells in hereditary carnitine deficiencyJournal of Inherited Metabolic Disease, 1989
- Primary Carnitine Deficiency Due to a Failure of Carnitine Transport in Kidney, Muscle, and FibroblastsNew England Journal of Medicine, 1988
- Hereditary defect in carnitine membrane transport is expressed in skin fibroblastsEuropean Journal of Pediatrics, 1988
- Pivampicillin-promoted excretion of pivaloylcarnitine in humansBiochemical Pharmacology, 1987
- Acylcarnitines in urine in medium-chain acyl-CoA dehydrogenase deficiency measured by quantitative high-pressure liquid chromatographyBiochemical Society Transactions, 1986
- Carnitine and glucuronic acid conjugates of pivalic acidXenobiotica, 1985
- Carnitine--metabolism and functionsPhysiological Reviews, 1983
- A method for the determination of carnitine in the picomole rangeClinica Chimica Acta; International Journal of Clinical Chemistry, 1972
- Propionylcarnitine physiological variations in vivoBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1968
- A REFERENCE BASE AND SYSTEM FOR ANALYSIS OF MUSCLE CONSTITUENTSPublished by Elsevier BV ,1950